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In this paper, we report the expression of PPHrz in the polarized cell line MDCK (Madin Darby canine kidney). In these cells, the enzyme was 
synthesized in an inactive proform, which upon treatment with trypsin was activated. The enzyme isolated from cell extracts was core-glycosylated 
and appeared to be retained in the ER as a homodimer. No PPHa was detectable on the surface of intact cells by immunofluorescence. However, 
a complex glycosylated soluble but inactive form was present in the culture medium, suggesting that proteolytic removal of the C-terminal membrane 
anchoring peptide leads to the secretion of PPHu. 
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1. INTRODUCTION 
PABA peptide hydrolase (PPH} is a metalloendopep- 
tidase of the human intestinal epitheli~ which belongs 
to the family of astacin proteases [l-3]. It is composed 
of two subunits, alpha and beta, which form multimeric 
structures. In the preceding paper we reported on the 
primary structure of the a subunit of PPH [4]. In com- 
mon with other members of the astacin family of pro- 
teases [5-121, PPHa displays a modular organi~tion of 
different structural domains, including the complete as- 
tacin protease domain with its characteristic extended 
zinc-binding motif, an adhesive domain and an EGF- 
like domain. PPHa is highly homologous to the alpha 
subunits of mouse and rat meprin [ 10,121. The NHz- 
terminal regions of these proteases contain putative sig- 
nal peptide and propeptide sequences and potential 
membrane anchoring domains which have been identi- 
fied near the COOH-termini. The three enzymes thus 
represent isoenzymes having species-specific differences 
in tissue expression and possibly also subunit assembly. 
Accordingly, PPHa has only been found in the gastroin- 
testinal tract in human [4], while in the mouse the a 
subunit of meprin appears kidney-specific [13,141, and 
in the rat it is expressed both in intestine and kidney 
[12]. The assembly of subunits seems also different in 
the three enzyme. While a4, a&, and /& configurations 
have been reported for the mouse enzyme [15], the rat 
enzyme has been described as a a/? heterodimer that 
forms (a& tetramers [ll]. By transiently expressing 
PPHa cDNA in COS-1 cells we have demonstrated the 
formation of a, homodimers [4]. 
Bond et al. have described latent forms of mouse 
meprin which could be activated in vitro by limited 
treatment with trypsin [13]. It is likely that the activa- 
tion of these proteases involves the proteolytic removal 
of the pro sequence. X-ray crystal structure analysis of 
the prototype of these proteases, astacin from the fresh 
water crayfish Ast~aclrs Javiatilis, indicated that the 
NH,-terminal alanine forms a salt-bridge with a glu- 
tamic acid residue close to the catalytic center [16,17]. 
The presence of a propeptide would clearly hinder such 
an a~angement. 
Here, we report on the expression of PPHa in polar- 
ized Madin Darby canine kidney (MDCK) cells. We 
show by amino acid sequencing, that the enzyme is 
synthesized in an inactive pro-form in these cells and 
that activation can be brought about by subsequent 
treatment with trypsin. The membrane-bold form of 
PPHa appears unable to exit the endoplasmic reticu- 
lum, but proteolytic processing leads to the secretion of 
a soluble form of the enzyme into the culture medium. 
2. EXPERIMENTAL 
2.1. Materials 
*Corresponding author. Fax: (41) (31) 631 37 37. 
Abbreviations: PPH, PABA peptide hydrolase; PPHa, alpha subunit 
of PABA peptide hydrolase; meprina, alpha subunit of meprin; FITC, 
fluorescein isothiocyanate. 
[‘%]Methionine (1,000 Ci/mmol) was from Du Pont NEN. Cell 
culture media, penicillin and streptomycin were obtained from 
GIBCO BRL. Fetal calf serum (FCS) was from Biological Industries. 
Phenylmethanesulphonyl fluoride (PMSF), pepstatin, aprotinin, leu- 
peptin, benzamidine, geneticin (G418), sodium butyrate and molecu- 
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lar weight standards were from Sigma Chemical CO. All restriction 
enzymes, T4 DNA ligase, DNA polymerase I, Klenow fragment, en- 
doglycosidase F, and endoglycosidase H were purchased from 
Boehringer Mannheim. Calf intestinal alkaline phosphatase was from 
Promega. The pXT1 and pSGS vectors were from Stratagene Cloning 
System. The protein A Sepharose beads were from Pharmacia Biosys- 
tern. All other chemicals were p.a. grade from Merck. 
2.2. Cells and cell culture 
MDCK cells (strain II) were kindly provided by Dr. Kai Simons 
(European Molecular Biology Laboratory). MDCK cells were grown 
in Eagle’s minimal essential medium with Earle’s salts (EMEM) sup- 
plemented with 5% (v/v) FCS, 100 units/ml of penicillin and lOO&ml 
of streptomycin. The medium was changed every 2 days. Transfected 
cells were grown in EMEM supplemented with 5% (v/v) FCS and 400 
&ml G418. 
2.3. Construction of meprin-PPH-alpha expression vector (pSGMPa) 
The vector for MPa expression was constructed as previously de- 
scribed [4]. Briefly, a -50 bp EcoRI-PstI fragment of PPHa lacking a 
start codon was substituted with a -200 bp 1FcoRI-PstI meprina DNA 
fragment containing an AUG start codon in pBluescript (Stratagene). 
The resulting -2.9 kbp BarnHI-BgfII fragment was inserted into the 
BarnHI-Bg[II sites of pSG5 yielding the pSGMPa expression vector. 
2.4. Antibodies 
Antibodies against a PPHa-glutathione-S-transferase fusion pro- 
tein were raised in rabbits as previously described [4]. 
2.5. Transfection of MDCK cells 
A two vector system was used to establish MDCK cell lines which 
permanently expressed the meprin-PPHa chimera. The ratio between 
the expression vector (pSGMPa) and the plasmid containing the neo 
resistance gene (pXT1) for selection was 1O:l. The transfection proce- 
dure has been described previously [18]. 
2.6. Determination of PPH activity 
MDCK9 cells were grown in 100 mm dishes and stimulated by 8 
mM sodium butyrate 16 h prior to enzyme activity determination. 
PPH activity was assayed according to Sterchi et al. [19]. 50~1 of lysed 
cells were incubated with 50 pl of N-bz+Tyr-p-amino benzoic acid 
(20 mmol/l final concentration in 50 mmohl Tris-HCl,l mmol/l MgCl,, 
pH 7.5) for at 37°C for 1 h. 
For trypsin activation, lysed MDCK9 cells were incubated with 10 
pug trypsin for 1 to 6 h, followed by inactivation of trypsin by the 
addition of 25 ~1 soja bean trypsin inhibitor (2 mg/ml). As a negative 
control, trypsin inhibitor was added together with the trypsin. 
2.7. Metabolic labelling 
Subconfluent MDCK9 cells (60 mm dishes) were stimulated with 8 
mM sodium butyrate 16 h before labelling [18]. The cells were incu- 
bated in methionine-free EMEM supplemented with 5% (v/v) dialyzed 
FCS for 1 h and were labelled with 50 PCi [‘5S]methionine (1Ci = 37 
GBq) for the times indicated in the figure legends. In some experiments 
the cells were chased after labelling in medium containing 10 mM 
non-radioactive methionine. 
2.8. Immunoprecipitation 
The cells were washed three times with ice-cold PBS, scraped off in 
1 ml ice-cold PBS and collected by low speed centrifugation. After lysis 
in 330 ~1 HB (25 mM Tris-HCl, 50 mM NaCl, pH 8.1), containing 1% 
(w/v) NP40,1% (w/v) DOC, 1 mM PMSF, lo&ml leupeptin, 2pg/ml 
pepstatin, 3.5 &ml benxamidine and 2 @ml aprotinin and removal 
of cell debris by high speed centrifugation, 7~1 of 20% (w/v) SDS was 
added and the proteins were denatured by boiling for 5 min. 0.7 ml 
HB, containing 1% Triton X-100 was added and the probes were 
precleared with Sepharose-A, followed by immunoprecipitation with 
rabbit anti PPHa antibody as described previously [4,20]. 
2.9. Endoglycosiakse H and endoglycosiakse F treatment 
After immunoprecipitation the samples were treated with the en- 
doglycosidases as previously described [20,21]. 
2.10. SDS-Polyacrylamide gel electrophoresis 
Proteins were analyzed on 7.5% polyacrylamide gels. Electro- 
phoretic separation was performed under reducing or nonreducing 
conditions. Fixation and fluorography were as described [21]. 
2.11. NH,-terminal amino acid sequence &termination 
MPa was immunoprecipitated from non-treated and trypsin-treated 
MDCK cell lysates as described above, subjected to SDS-PAGE and 
transblotted onto Problot membrane (Applied Biosystems). Coomas- 
sie-stained bands were excised and loaded onto an automatic model 
477 sequencer from Applied Biosysmms. 
2.12. Immunojluorescence staining 
Postconfluent MDCK9 cells grown on glass coverslips were fixed 
in 3% paraformaldehyde in PBS+ (PBS with 0.1 mM Ca” and 0.5 mM 
Me) for 20 min. The cells were washed three times with PBS and 
incubated with 50 mM NH&l in PBS for 20 min. The cells were 
washed again and incubated with the first antibody (rabbit antiPPHa, 
diluted 1:20 in PBS supplemented with 2% FCS) for 30 min. The cells 
were washed twice with PBS-296 FCS and once with PBS, the second 
antibody (FIT&conjugated swine antirabbit IgG from Dako, Den- 
mark, diluted 1:20 with PBS-2% FCS) incubated for 30 min and 
washed as described above. The coverslips were covered in mounting 
medium (Sigma). For intracellular staining, the cells were permeabil- 
ized with 0.1% Triton X-100 in PBS after fixation in paraformalde- 
hyde. All procedures were performed at room temperature. 
3. RESULTS AND DISCUSSION 
We have transfected MDCK cells with a cDNA con- 
struct coding for a chimeric enzyme, MPa, composed 
of the entire mature alpha subunit of human PPH and 
the NH,-terminus from the alpha subunit of mouse me- 
prin A which included the putative signal sequence and 
part of the putative propeptide sequence (Fig. 1). Clone 
MDCK9 which permanently expressed this chimer-k 
protein was isolated and used for the studies described 
here. 
3.1. Synthesis of an inactiveproenzyme and activation by 
trypsin 
MDCK9 cells and culture medium exhibited no PPH 
activity using N-Benzoyl-L-tyrosine-p-amino benzoic 
acid as substrate. However, treatment of lysed MDCK9 
cells with trypsin lead to activation of the enzyme (Fig. 
2). NH,-terminal amino acid sequencing of the inactive 
form of MPa revealed the sequence VSIKHL (under- 
\ A . / - 
Slpml ppw. Pm ppnd. 
Fig. 1. NH,-terminal amino acid sequence of MPa with cleavage sites 
for proteloytic processing. The amino acid sequence from meprina is 
indicated. For detail of construction of the meprin-PPHa chimera 
(MPa) see Dumermuth et al. [4]. The NH,-terminal amino acid se- 
quences (underlined) of inactive MPa (NH,i) and active PPHa are 
VSIKHL and NGLR respectively. In addition, the signal peptide and 
the propeptide sequences are indicated. 
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lined in Fig. l), thus confirming the site of the signal 
peptide cleavage. The NH,-terminal sequence of the 
detergent solubilized mature PPHcl (NGLR) is also in- 
dicated in Fig. 1. An activating process involving prote- 
olytic removal of a propeptide by a trypsin-like enzyme 
is thus a crucial step in the biogenesis of active PPH. 
This is in agreement with recent reports on the X-ray 
crystal structure of astacin [ 17,221. Clearly, MDCK cells 
lack the enzyme for this processing step. Comparison of 
the NH,-terminal amino acid sequence of PPHol and 
PPI-I/? [4], solubilized from microvillus membrane of 
human enterocytes by nonionic detergents, indicate 
that, in the intestine, both subunits are proteolytically 
processed. This is in contrast to meprin isolated from 
mouse kidneys, where processing has only been shown 
for the alpha subunit [23]. The site of proteolytic proc- 
essing and thus activation is not known. Processing of 
both subunits in the human intestine suggest hat this 
process might be mediated by pancreatic trypsin. 
3.2. A membrane-bound form of the enzyme is retained 
in the ER 
Metabolic labelling of MDCK9 cells, ,followed by im- 
munoprecipitation from solubilized cell extracts led to 
the isolation of an immature form of the enzyme. A 
major protein with an apparent M, = 100 kDa was syn- 
thesized which was sensitive to treatment with endogly- 
cosidase H (Fig. 3A). This sensitivity to Endo H diges- 
tion was retained for prolonged chase times, indicating 
that the protein was retained in the ER. Pulse chase 
labelling experiments, followed by analysis of im- 
munoprecipitated MPa by SDS-PAGE under non-re- 
ducing conditions revealed the occurence of disulfide 
bridged homodimers (Fig. 3B). The rapid, formation of 
these homodimers contirms our previous findings from 
organ cultured human small intestinal explants [2] and 
from transiently transfected COS-1 cells [4]. It is also 
consistent with the classical function of protein disulfide 
isomerase, an ER enzyme which mediates protein fold- 
ing [24]. 
spec. act. 
NJ/g protein 
0 1 2 4 6 
h of trypsin treatment 
Fig. 2. Activation of PPH activity by trypsin. Transfected MDCK9 
cells were lysed with nonionic detergents 16 h after stimulation with 
sodium butyrate (see methods). Activity of MPcc was measured against 
N-benzoyl-r,-tyrosine-p-aminobenzoic acid (PABA peptide) before 
and after treatment with trypsin. 
A 
1 2 3 4 5 6 7 6 9 10 11 12 13 14 
97 kDa _ 
70 kDa_ 
0 1 2 3 4 5 22 h chase 
- + -+ - +-+ -+ - +- + endo H 
B 
1 2 345 6 7 
0 1 2 3 4 5 22 h chase 
Fig. 3. Metabolic labelling of transfected MDCK9 cells with 
[35S]methionine. 16 h after stimulation with sodium butyrate, cells 
were pulse-labelled for 15 min and chased for the times indicated (Fig. 
3 A,B), immunoprecipitated and analyzed by SDS-PAGE and fluoro- 
graphy. Endo H treatment of immunoprecipitated proteins was as 
described [20,21]. (A) Proteins immunoprecipitated from lysed cells 
and analyzed by SDS-PAGE under reducing conditions (7.5% gel). 
Position of molecular markers are shown on the left. (B) Proteins 
immunoprecipitated from lysed cells and analyzed by SDS-PAGE 
under non-reducing conditions (7.5% gel). Position of molecular 
markers are shown on the left. 
3.3. No enzyme is found on the cell surface of MDCK9 
cells 
Localization of MPa in MDCK9 cells was studied by 
immunofluorescence labelling, using the PPHa-specific 
antibodies [4]. When intact MDCK9 cells were labelled, 
no signal was obtained, indicating that the antibodies 
had no access to the synthesized protein (Fig. 4B). In 
contrast, when the cells were permeabilized with Triton 
X-100 prior to immunofluorescence labelling, a strong 
signal was obtained (Fig. 4D). The pattern of the la- 
belling obtained with permeabilized cells was character- 
istic to ER. These findings are consistent with the syn- 
thesis of a transport-incompetent membrane-bound 
form of the enzyme. In human small intestinal mucosa, 
PPH was localized to the microvillus membrane by im- 
munofluorecence [25] and immuno-electronmicroscopy 
VI* 
3.4. A solubleform of the enzyme is present in the culture 
medium 
A decline of the signal was observed after longer 
chase times and no endo H resistant form was detecta- 
ble intracellularly. This suggested to us that the newly 
synthesized protein was either degraded or processed 
further. To investigate this, the culture medium of 
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Fig. 4. bnmunofluorescence of transfected MDCK9 cells. Cells grown 
on glass coverslips were fixed with 3% parafotmaldehyde as described 
in Section 2. The first antibody was a rabbit antiPPHa, the second 
antibody was a FITC-conjugated swine antirabbit IgG. A, cell mono- 
layer of intact MDCK9 cells viewed with Normarsky optics, and B, 
the same section with ~~ofluor~n~ staining. C, cell monolayer 
of MDCK9 cells ~~ea~~~ with T&on X-100 ~o~arsky~, and 
D, the same section with immunofluorescence staining, 
metabolically labelled MDCK9 cells was immunopre- 
cipitated. Surprisingly, a soluble, endo H resistant form 
of the enzyme was found (Fig. 5). The enzyme appeared 
as a double band, both bands displaying a partial resis- 
tance to endo H digestion. The nature of these double 
bands are unknown. This indicates, that complex glyco- 
sylation had occurred, but that not all six potential 
N-linked glycosylation sites were affected. For secretion 
of the enzyme to occur, and assuming that the putative 
anchor domain actually functions as such, a proteolytic 
processing step leading to the removal of the anchor 
sequence must be proposed. The site where this trunca- 
tion occurs is not known, but the lack of endo H-resis- 
tant forms in the cells suggests that this might be an ER 
event. Transmembr~e regions of type I membrane pro- 
teins have been implicated as signals for retention in the 
ER [26]. Maybe the transmembrane domain in PPH& 
has a similar function, possibly to aid oligomerization 
and proper folding prior to rapid transport to the cell 
surface. 
Taken together, these data strongly suggest, that a 
truncated form of PPHa containing the protease do- 
main, the adhesive domain and the EGF-like domain is 
1 2 
- 97 kDa 
end0 H 
Fig. 5. Immunoisolation of MPa from culture medium of metaboli- 
cally labelled MDCK9 cells. Metaboli~y labelled proteins (continu- 
ously for 16 h) were ~rn~opr~pitat~ from the culture medium of 
transfected MDCK9 cells, and analyzed by SDS-PAGE under reduc- 
ing conditions (7.5% gel). One sample was treated with endo H prior 
to analysis (lane 1). 
secreted into the lumen of the small intestine. New ap 
proaches will be needed to study the role of this mul- 
tidomain protein in gut physiology. 
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